nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—DRD2—attention deficit hyperactivity disorder	0.683	1	CbGaD
Amantadine—GRIN2C—forebrain—attention deficit hyperactivity disorder	0.00496	0.0446	CbGeAlD
Amantadine—GRIN2D—forebrain—attention deficit hyperactivity disorder	0.00461	0.0415	CbGeAlD
Amantadine—GRIN3A—forebrain—attention deficit hyperactivity disorder	0.00433	0.039	CbGeAlD
Amantadine—GRIN1—forebrain—attention deficit hyperactivity disorder	0.00411	0.037	CbGeAlD
Amantadine—GRIN2B—forebrain—attention deficit hyperactivity disorder	0.00392	0.0353	CbGeAlD
Amantadine—GRIN2A—forebrain—attention deficit hyperactivity disorder	0.00343	0.0308	CbGeAlD
Amantadine—DDC—forebrain—attention deficit hyperactivity disorder	0.0032	0.0288	CbGeAlD
Amantadine—GRIN1—midbrain—attention deficit hyperactivity disorder	0.00271	0.0244	CbGeAlD
Amantadine—GRIN2C—nervous system—attention deficit hyperactivity disorder	0.00269	0.0242	CbGeAlD
Amantadine—GRIN2C—central nervous system—attention deficit hyperactivity disorder	0.00259	0.0233	CbGeAlD
Amantadine—GRIN2C—cerebellum—attention deficit hyperactivity disorder	0.00253	0.0228	CbGeAlD
Amantadine—GRIN2D—nervous system—attention deficit hyperactivity disorder	0.0025	0.0225	CbGeAlD
Amantadine—GRIN2D—central nervous system—attention deficit hyperactivity disorder	0.00241	0.0217	CbGeAlD
Amantadine—GRIN2D—cerebellum—attention deficit hyperactivity disorder	0.00235	0.0212	CbGeAlD
Amantadine—GRIN3A—nervous system—attention deficit hyperactivity disorder	0.00235	0.0212	CbGeAlD
Amantadine—GRIN3A—central nervous system—attention deficit hyperactivity disorder	0.00227	0.0204	CbGeAlD
Amantadine—GRIN2A—midbrain—attention deficit hyperactivity disorder	0.00226	0.0203	CbGeAlD
Amantadine—GRIN1—nervous system—attention deficit hyperactivity disorder	0.00223	0.0201	CbGeAlD
Amantadine—GRIN1—central nervous system—attention deficit hyperactivity disorder	0.00215	0.0193	CbGeAlD
Amantadine—GRIN2B—nervous system—attention deficit hyperactivity disorder	0.00213	0.0191	CbGeAlD
Amantadine—DDC—midbrain—attention deficit hyperactivity disorder	0.00211	0.019	CbGeAlD
Amantadine—GRIN1—cerebellum—attention deficit hyperactivity disorder	0.0021	0.0189	CbGeAlD
Amantadine—GRIN2C—brain—attention deficit hyperactivity disorder	0.00206	0.0185	CbGeAlD
Amantadine—GRIN2B—central nervous system—attention deficit hyperactivity disorder	0.00205	0.0184	CbGeAlD
Amantadine—GRIN2B—cerebellum—attention deficit hyperactivity disorder	0.002	0.018	CbGeAlD
Amantadine—GRIN2D—brain—attention deficit hyperactivity disorder	0.00191	0.0172	CbGeAlD
Amantadine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00186	0.0167	CbGeAlD
Amantadine—GRIN2A—nervous system—attention deficit hyperactivity disorder	0.00186	0.0167	CbGeAlD
Amantadine—GRIN3A—brain—attention deficit hyperactivity disorder	0.0018	0.0162	CbGeAlD
Amantadine—GRIN2A—central nervous system—attention deficit hyperactivity disorder	0.00179	0.0161	CbGeAlD
Amantadine—GRIN2A—cerebellum—attention deficit hyperactivity disorder	0.00175	0.0157	CbGeAlD
Amantadine—DDC—nervous system—attention deficit hyperactivity disorder	0.00174	0.0156	CbGeAlD
Amantadine—GRIN1—brain—attention deficit hyperactivity disorder	0.0017	0.0153	CbGeAlD
Amantadine—DDC—central nervous system—attention deficit hyperactivity disorder	0.00167	0.015	CbGeAlD
Amantadine—MAOB—forebrain—attention deficit hyperactivity disorder	0.00165	0.0148	CbGeAlD
Amantadine—GRIN2B—brain—attention deficit hyperactivity disorder	0.00163	0.0146	CbGeAlD
Amantadine—GRIN2A—brain—attention deficit hyperactivity disorder	0.00142	0.0128	CbGeAlD
Amantadine—MAOB—cardiovascular system—attention deficit hyperactivity disorder	0.00139	0.0125	CbGeAlD
Amantadine—DRD2—forebrain—attention deficit hyperactivity disorder	0.00139	0.0125	CbGeAlD
Amantadine—DDC—brain—attention deficit hyperactivity disorder	0.00133	0.0119	CbGeAlD
Amantadine—SIGMAR1—midbrain—attention deficit hyperactivity disorder	0.00114	0.0102	CbGeAlD
Amantadine—MAOB—midbrain—attention deficit hyperactivity disorder	0.00109	0.00978	CbGeAlD
Amantadine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00101	0.00909	CbGeAlD
Amantadine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000973	0.00875	CbGeAlD
Amantadine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000918	0.00825	CbGeAlD
Amantadine—MAOB—nervous system—attention deficit hyperactivity disorder	0.000894	0.00804	CbGeAlD
Amantadine—SIGMAR1—cerebellum—attention deficit hyperactivity disorder	0.000879	0.0079	CbGeAlD
Amantadine—MAOB—central nervous system—attention deficit hyperactivity disorder	0.000861	0.00774	CbGeAlD
Amantadine—MAOB—cerebellum—attention deficit hyperactivity disorder	0.000841	0.00757	CbGeAlD
Amantadine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000773	0.00695	CbGeAlD
Amantadine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000754	0.00678	CbGeAlD
Amantadine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000726	0.00653	CbGeAlD
Amantadine—SIGMAR1—brain—attention deficit hyperactivity disorder	0.000714	0.00642	CbGeAlD
Amantadine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.00071	0.00638	CbGeAlD
Amantadine—MAOB—brain—attention deficit hyperactivity disorder	0.000683	0.00615	CbGeAlD
Amantadine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000601	0.0054	CbGeAlD
Amantadine—DRD2—brain—attention deficit hyperactivity disorder	0.000577	0.00519	CbGeAlD
Amantadine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000508	0.00457	CbGeAlD
Amantadine—GRIN2B—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000401	0.00195	CbGpPWpGaD
Amantadine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000397	0.00357	CbGeAlD
Amantadine—GRIN1—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.000396	0.00193	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000391	0.0019	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000389	0.00189	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.000386	0.00188	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000381	0.00185	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000381	0.00185	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000378	0.00184	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000378	0.00184	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000377	0.00183	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000374	0.00182	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000371	0.0018	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000369	0.00179	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.000364	0.00177	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000361	0.00175	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000358	0.00174	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000358	0.00174	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000355	0.00172	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000353	0.00172	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000351	0.00171	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000351	0.00171	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000348	0.00169	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000345	0.00168	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000344	0.00167	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000339	0.00165	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000337	0.00164	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000336	0.00163	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000334	0.00162	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00033	0.00161	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000328	0.0016	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000328	0.0016	CbGpPWpGaD
Amantadine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000326	0.00293	CbGeAlD
Amantadine—GRIN2B—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00032	0.00156	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00032	0.00155	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000315	0.00153	CbGpPWpGaD
Amantadine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000314	0.00282	CbGeAlD
Amantadine—GRIN2D—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000313	0.00152	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00031	0.00151	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00031	0.00151	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000307	0.00149	CbGpPWpGaD
Amantadine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000307	0.00276	CbGeAlD
Amantadine—GRIN2B—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000302	0.00147	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000302	0.00147	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000298	0.00145	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000293	0.00142	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000291	0.00141	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000289	0.0014	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000286	0.00139	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000286	0.00139	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000285	0.00139	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000285	0.00139	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000284	0.00138	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000283	0.00138	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.000283	0.00137	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.000279	0.00136	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.000276	0.00134	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000275	0.00134	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000273	0.00133	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.000272	0.00132	CbGpPWpGaD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000272	0.00132	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000271	0.00132	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000266	0.00129	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000264	0.00128	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000264	0.00128	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000257	0.00125	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000255	0.00124	CbGpPWpGaD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000253	0.00123	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000252	0.00122	CbGpPWpGaD
Amantadine—ABCB1—brain—attention deficit hyperactivity disorder	0.000249	0.00224	CbGeAlD
Amantadine—GRIN2B—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000249	0.00121	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000249	0.00121	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000247	0.0012	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000246	0.00119	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000245	0.00119	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000243	0.00118	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000241	0.00117	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00024	0.00117	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000224	0.00109	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000223	0.00108	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000219	0.00106	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000219	0.00106	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000218	0.00106	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000217	0.00106	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000217	0.00105	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000214	0.00104	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000199	0.000969	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000199	0.000968	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000194	0.000944	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000191	0.000928	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000191	0.000927	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000189	0.00092	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000188	0.000912	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000187	0.000909	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000186	0.000904	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000185	0.000897	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000184	0.000893	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000182	0.000886	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00018	0.000876	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000178	0.000864	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000172	0.000835	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000171	0.000832	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000171	0.00083	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000168	0.000816	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000164	0.000795	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000163	0.000792	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00016	0.000779	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000159	0.000773	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000153	0.000741	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000152	0.00074	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000152	0.000737	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000151	0.000735	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00015	0.000729	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00015	0.000729	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000145	0.000706	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000145	0.000706	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000142	0.000692	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000142	0.000692	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000142	0.000689	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000141	0.000686	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000141	0.000684	CbGpPWpGaD
Amantadine—DDC—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000134	0.00065	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000132	0.000643	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000131	0.000637	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000131	0.000636	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00013	0.000633	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00013	0.00063	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000129	0.000629	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000128	0.000624	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000128	0.000623	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.000613	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000125	0.000605	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000124	0.000601	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000123	0.0006	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000123	0.000597	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000122	0.000595	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000122	0.000593	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000121	0.000586	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00012	0.000582	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000119	0.000579	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000117	0.000569	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000117	0.000567	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000116	0.000562	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000115	0.000559	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000113	0.000551	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000113	0.000547	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000111	0.00054	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000109	0.000528	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000105	0.000512	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000102	0.000496	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.000487	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	9.92e-05	0.000482	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.9e-05	0.000481	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.87e-05	0.00048	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	9.85e-05	0.000478	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	9.84e-05	0.000478	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	9.39e-05	0.000456	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	9.24e-05	0.000449	CbGpPWpGaD
Amantadine—DDC—Metabolism—TPH2—attention deficit hyperactivity disorder	9.23e-05	0.000448	CbGpPWpGaD
Amantadine—DDC—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.23e-05	0.000448	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	9.18e-05	0.000446	CbGpPWpGaD
Amantadine—DDC—Metabolism—DPYD—attention deficit hyperactivity disorder	9.08e-05	0.000441	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.63e-05	0.000419	CbGpPWpGaD
Amantadine—DDC—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.44e-05	0.00041	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.21e-05	0.000399	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.05e-05	0.000391	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.02e-05	0.00039	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.77e-05	0.000377	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TPH2—attention deficit hyperactivity disorder	7.77e-05	0.000377	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.77e-05	0.000377	CbGpPWpGaD
Amantadine—MAOB—Metabolism—DPYD—attention deficit hyperactivity disorder	7.64e-05	0.000371	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.63e-05	0.000371	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.54e-05	0.000366	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.54e-05	0.000366	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.46e-05	0.000362	CbGpPWpGaD
Amantadine—DDC—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.38e-05	0.000358	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	7.36e-05	0.000358	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.31e-05	0.000355	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.1e-05	0.000345	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	7.03e-05	0.000342	CbGpPWpGaD
Amantadine—DDC—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.02e-05	0.000341	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.57e-05	0.000319	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.46e-05	0.000314	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.27e-05	0.000305	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.21e-05	0.000302	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.97e-05	0.00029	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.91e-05	0.000287	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.84e-05	0.000284	CbGpPWpGaD
Amantadine—DDC—Metabolism—COMT—attention deficit hyperactivity disorder	5.59e-05	0.000272	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.58e-05	0.000271	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.56e-05	0.00027	CbGpPWpGaD
Amantadine—DDC—Metabolism—MAOA—attention deficit hyperactivity disorder	5.55e-05	0.00027	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EP300—attention deficit hyperactivity disorder	5.18e-05	0.000252	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.13e-05	0.000249	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.06e-05	0.000246	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EP300—attention deficit hyperactivity disorder	5.05e-05	0.000245	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.92e-05	0.000239	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.88e-05	0.000237	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.88e-05	0.000237	CbGpPWpGaD
Amantadine—MAOB—Metabolism—COMT—attention deficit hyperactivity disorder	4.71e-05	0.000229	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MAOA—attention deficit hyperactivity disorder	4.67e-05	0.000227	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.53e-05	0.00022	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.43e-05	0.000215	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.41e-05	0.000214	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.39e-05	0.000213	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.32e-05	0.00021	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.31e-05	0.00021	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.26e-05	0.000207	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.23e-05	0.000206	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.12e-05	0.0002	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.12e-05	0.0002	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.12e-05	0.0002	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	4.05e-05	0.000197	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.99e-05	0.000194	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.92e-05	0.00019	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.87e-05	0.000188	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	3.84e-05	0.000187	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.84e-05	0.000187	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	3.78e-05	0.000184	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.77e-05	0.000183	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.51e-05	0.000171	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.43e-05	0.000166	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.29e-05	0.00016	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.26e-05	0.000159	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	3.15e-05	0.000153	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.14e-05	0.000152	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.07e-05	0.000149	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.99e-05	0.000145	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.92e-05	0.000142	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.78e-05	0.000135	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.62e-05	0.000127	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.52e-05	0.000123	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.5e-05	0.000121	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.48e-05	0.00012	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.43e-05	0.000118	CbGpPWpGaD
Amantadine—DDC—Metabolism—EP300—attention deficit hyperactivity disorder	2.4e-05	0.000117	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.35e-05	0.000114	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	2.33e-05	0.000113	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.31e-05	0.000112	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.31e-05	0.000112	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.29e-05	0.000111	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.25e-05	0.000109	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.25e-05	0.000109	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.21e-05	0.000108	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.06e-05	0.0001	CbGpPWpGaD
Amantadine—MAOB—Metabolism—EP300—attention deficit hyperactivity disorder	2.02e-05	9.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.8e-05	8.75e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.71e-05	8.33e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.49e-05	7.25e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.36e-05	6.63e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.35e-05	6.58e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.07e-05	5.2e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	9.98e-06	4.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.9e-06	3.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	5.85e-06	2.84e-05	CbGpPWpGaD
